Active, not recruitingPHASE2, PHASE3NCT05832034

Add-on Intravenous Immunoglobulins in Early Myositis

Studying Antisynthetase syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Principal Investigator
Raaphorst, MD, PhD
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Intervention
Immune Globulin Intravenous (Human)(drug)
Enrollment
44 enrolled
Eligibility
18 years · All sexes
Timeline
20212026

Study locations (1)

Collaborators

Princess Beatrix Muscle Foundation · Prothya Biosolutions

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05832034 on ClinicalTrials.gov

Other trials for Antisynthetase syndrome

Additional recruiting or active studies for the same condition.

See all trials for Antisynthetase syndrome

← Back to all trials